UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 206

Sortiert nach

Benign prostatic hyperplasia – what do we know?

BJU international, 2021-04, Vol.127 (4), p.389-399

2021

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers

Oncotarget, 2016-08, Vol.7 (32), p.51965-51980

2016

Link zum Volltext

Verfügbarkeit prüfen

Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells

PloS one, 2013-05, Vol.8 (5), p.e64278

2013

Link zum Volltext

Verfügbarkeit prüfen

ETS transcription factor ELF3 (ESE‐1) is a cell cycle regulator in benign and malignant prostate

FEBS open bio, 2022-07, Vol.12 (7), p.1365-1387

2022

Link zum Volltext

Verfügbarkeit prüfen

Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer

Molecular cancer, 2011-07, Vol.10 (1), p.94-94

2011

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of Placental Growth Factor in Stromal Cells from Benign Prostatic Hyperplasia: Another Piece in the Puzzle?

European urology open science (Online), 2020-10, Vol.21, p.29-32

2020

Link zum Volltext

Verfügbarkeit prüfen

Conserved Two-Step Regulatory Mechanism of Human Epithelial Differentiation

Stem cell reports, 2014-02, Vol.2 (2), p.180-188

2014

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer

Oncotarget, 2017-08, Vol.8 (34), p.56698-56713

2017

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA Expression Profile of Primary Prostate Cancer Stem Cells as a Source of Biomarkers and Therapeutic Targets

European urology, 2015-01, Vol.67 (1), p.7-10

2015

Link zum Volltext

Verfügbarkeit prüfen

Re: Yves Allorya, Willemien Beukers, Ana Sagrera, et al. Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome. Eur Urol 2014;65:360–6: Telomerase Expression and Stem Cells: Urologic Epithelial Perspective

European urology, 2014-06, Vol.65 (6), p.e85-e86

2014

Link zum Volltext

Verfügbarkeit prüfen

Notch signalling is a potential resistance mechanism of progenitor cells within patient‐derived prostate cultures following ROS‐inducing treatments

FEBS letters, 2020-01, Vol.594 (2), p.209-226

2020

Link zum Volltext

Verfügbarkeit prüfen

Phenotype-independent DNA methylation changes in prostate cancer

British journal of cancer, 2018-10, Vol.119 (9), p.1133-1143

2018

Link zum Volltext

Verfügbarkeit prüfen

Telomerase Activity and Telomere Length in Human Benign Prostatic Hyperplasia Stem-like Cells and Their Progeny Implies the Existence of Distinct Basal and Luminal Cell Lineages

European urology, 2016-04, Vol.69 (4), p.551-554

2016

Link zum Volltext

Verfügbarkeit prüfen

Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells

Nature communications, 2013, Vol.4 (1), p.1623-1623, Article 1623

2013

Link zum Volltext

Verfügbarkeit prüfen

Re: Yves Allorya, Willemien Beukers, Ana Sagrera, et al. Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome. Eur Urol 2014;65:360–6

European urology, 2014-06, Vol.65 (6), p.e85-e86

2014

Link zum Volltext

Verfügbarkeit prüfen

Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data

British journal of cancer, 2015-08, Vol.113 (4), p.611-615

2015

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis

Cancer medicine (Malden, MA), 2016-01, Vol.5 (1), p.61-73

2016

Link zum Volltext

Verfügbarkeit prüfen

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness

European urology oncology, 2018-12, Vol.1 (6), p.449-458

2018

Link zum Volltext

Verfügbarkeit prüfen

A technique for knotting looped polydiaxone during abdominal wound closure

Annals of the Royal College of Surgeons of England, 2009-11, Vol.91 (8), p.714

2009

Link zum Volltext

Verfügbarkeit prüfen

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

The Lancet (British edition), 2022-01, Vol.399 (10323), p.447-460

2022

Link zum Volltext

Verfügbarkeit prüfen

Orthotopic neobladder perforation: an unusual presentation of small bowel obstruction

Journal of surgical case reports, 2013-07, Vol.2013 (7), p.rjt045-rjt045

2013

Link zum Volltext

Verfügbarkeit prüfen

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

The lancet oncology, 2023-05, Vol.24 (5), p.443-456

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract B25: DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (13_Supplement), p.B25-B25

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5198: Elucidation of dynamic prostate epithelial hierarchy: Insights into transcriptional and epigenetic regulatory mechanisms

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5198-5198

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5209: Prostate cancer progenitor cells have distinct DNA methylation profile which changes upon differentiation

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5209-5209

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(182)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Benign prostatic hyperplasia – what do we know?

Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers

Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells

ETS transcription factor ELF3 (ESE‐1) is a cell cycle regulator in benign and malignant prostate

Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer

Overexpression of Placental Growth Factor in Stromal Cells from Benign Prostatic Hyperplasia: Another Piece in the Puzzle?

Conserved Two-Step Regulatory Mechanism of Human Epithelial Differentiation

Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer

MicroRNA Expression Profile of Primary Prostate Cancer Stem Cells as a Source of Biomarkers and Therapeutic Targets

Notch signalling is a potential resistance mechanism of progenitor cells within patient‐derived prostate cultures following ROS‐inducing treatments

Phenotype-independent DNA methylation changes in prostate cancer

Telomerase Activity and Telomere Length in Human Benign Prostatic Hyperplasia Stem-like Cells and Their Progeny Implies the Existence of Distinct Basal and Luminal Cell Lineages

Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells

Re: Yves Allorya, Willemien Beukers, Ana Sagrera, et al. Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome. Eur Urol 2014;65:360–6

Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data

Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness

A technique for knotting looped polydiaxone during abdominal wound closure

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

Orthotopic neobladder perforation: an unusual presentation of small bowel obstruction

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

Abstract B25: DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation

Abstract 5198: Elucidation of dynamic prostate epithelial hierarchy: Insights into transcriptional and epigenetic regulatory mechanisms

Abstract 5209: Prostate cancer progenitor cells have distinct DNA methylation profile which changes upon differentiation

Suchergebnisse filtern